Martin Schlesinger

β1-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters

Fabian Baltes, Vladlena Pfeifer, Katja Silbermann et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2020 · 79 citations

Type 1, β1-Integrin Binding, Cell Adhesion +12

Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

Anna Raynor, Peter Jantscheff, T Ross et al. · Lipids in Health and Disease · 2015 · 72 citations · Full text

VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes

Manuela Călin, Daniela Stan, Martin Schlesinger et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2014 · 55 citations

Inflammation, Signal Transduction, Cell Adhesion +11

Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion <i>In vitro</i> and Inhibits Metastasis-Like Lung Invasion <i>In vivo</i>

Peter Jantscheff, Martin Schlesinger, Juliane Fritzsche et al. · Molecular Cancer Therapeutics · 2011 · 54 citations · Full text

A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies

Savita Bisht, Martin Schlesinger, Alexander Rupp et al. · Journal of Nanobiotechnology · 2016 · 51 citations · Full text